Berikutnya

Putar otomatis

Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma

0 Tampilan • 07/18/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Andrew Wagner, MD, PhD; Lor Randall, MD, FACS; Shreyaskumar Patel, MD; and Jonathan Trent, MD, PhD; discuss the factors they consider when balancing the risks and benefits of chemotherapy treatment in soft tissue sarcoma.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis